NuVasive, Inc. news

   Watch this stock
Showing stories 1 - 2 of about 2   

Articles published

NUVA 53.75 +1.00 (1.90%)
price chart
An Interview with Thomas Einhorn, MD
HealthpointCapital: Congratulations on receiving the Distinguished Investigator Award from ORS and OREF, honoring your research and academic contributions to the orthopedics space.
Biotech vets back $22MA round for neuroscience startup
The former CEO of Alba Therapeutics, Blake Paterson, has put together a $22 million A round to launch his new biotech in Baltimore.